Dr.Fitzpatrick Interviewed by Scientific American

Written By Anthony Fitzpatrick

In an interview with the Scientific American, Dr. Anthony Fitzpatrick discusses the signficance of structural diversity in tauopathy strains and their implications in developing therapeutic targets for disease.

Tau Shows Promise as Achilles’ Heel for Alzheimer’s and Similar Diseases

Anthony Fitzpatrick
Previous

Congratulations Christina Lee for winning the Bridges & Sturtevant Prize in Biological Sciences!
Next

Fitzpatrick Lab undergrads publish in Cell